Xavier Bertrand appointed vice president of Peripheral Interventions for Boston Scientific in EMEA, leading the charge in minimally invasive therapies for arterial, venous and cancer diseases.

April 3, 2023

Boston Scientific announces the appointment of Xavier Bertrand as the new vice president for the Peripheral Interventions division in Europe, Middle East and Africa (EMEA). Xavier brings over 17 years of diverse experience to his new position, having held various leadership roles across sales, marketing, business development and finance at Boston Scientific.  

Xavier is passionate about leveraging his skills to make an impact and drive innovation and growth across the region. Xavier was drawn to the Peripheral Interventions business due to its wide range of solutions and potential for impact.  
 
“I am truly passionate about innovation and growth and am eager to take on the challenge of leading the Peripheral Interventions business in EMEA,” said Xavier. "It's a privilege to be part of a company that's dedicated to improving healthcare outcomes, and I look forward to working collaboratively with the Peripheral Interventions team and other colleagues at Boston Scientific to make a positive difference to our customers and the patients they serve.” 
 
The company’s innovative solutions have helped transform the way healthcare professionals diagnose and treat these conditions, resulting in improved patient outcomes and quality of life. With Xavier Bertrand as vice president for Peripheral Interventions in EMEA, the company continues its aim of bringing to market the latest minimally invasive technologies and solutions for the treatment of patients with arterial disease, venous disease and cancer.